Results 311 to 320 of about 529,025 (348)
Some of the next articles are maybe not open access.
Molecular Reproduction and Development, 2007
AbstractThere is evidence that several fibroblast growth factors (FGFs) are involved in growth and development of the corpus luteum (CL), but many FGFs have not been investigated in this tissue, including FGF10. The objective of this study was to determine if FGF10 and its receptor (FGFR2B) are expressed in the CL.
Castilho, A. C.+7 more
openaire +4 more sources
AbstractThere is evidence that several fibroblast growth factors (FGFs) are involved in growth and development of the corpus luteum (CL), but many FGFs have not been investigated in this tissue, including FGF10. The objective of this study was to determine if FGF10 and its receptor (FGFR2B) are expressed in the CL.
Castilho, A. C.+7 more
openaire +4 more sources
Journal of Neuro-Oncology, 1994
Malignant astrocytomas are highly invasive, vascular neoplasms that comprise the majority of nervous system tumors in humans. A strong association has previously been made between malignancy in human astrocytic tumors and increased expression of certain fibroblast growth factor (FGF) family members, including basic and acidic FGF.
Fumio Yamaguchi+6 more
openaire +3 more sources
Malignant astrocytomas are highly invasive, vascular neoplasms that comprise the majority of nervous system tumors in humans. A strong association has previously been made between malignancy in human astrocytic tumors and increased expression of certain fibroblast growth factor (FGF) family members, including basic and acidic FGF.
Fumio Yamaguchi+6 more
openaire +3 more sources
Plastic and Reconstructive Surgery, 1998
Craniosynostosis is a common disorder with an unknown etiology. Recent genetic mapping studies have demonstrated a strong linkage between several familial craniosynostotic syndromes and mutations in fibroblast growth factor receptor 1 (FGF-R1) and 2 (FGF-R2).
Michael T. Longaker+4 more
openaire +3 more sources
Craniosynostosis is a common disorder with an unknown etiology. Recent genetic mapping studies have demonstrated a strong linkage between several familial craniosynostotic syndromes and mutations in fibroblast growth factor receptor 1 (FGF-R1) and 2 (FGF-R2).
Michael T. Longaker+4 more
openaire +3 more sources
Angiogenesis, Fibroblast Growth Factors, and Their Receptors
1999The key determinants defining the earliest events in angiogenesis, vas-culogenesis, and the molecular differences that distinguish arteries from veins are now better understood than at any time to date. The adult vasculature consists of large arteries that progressively branch into smaller and smaller vessels terminating into precapillary arterioles ...
openaire +2 more sources
Modulation of the epidermal growth factor receptor by basic fibroblast growth factor
Journal of Cellular Physiology, 1993AbstractTreatment of Swiss 3T3 fibroblasts with basic fibroblast growth factor (bFGF) lead to a rapid reduction in epidermal growth factor (EGF) binding and a slower inhibition of EGF receptor autophosphorylation. The reduction in binding was due to a complete loss of the highest affinity EGF binding sites and a reduction in the lower affinity binding ...
openaire +3 more sources
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel+2 more
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
Nature Genetics, 1996Jennifer S. Colvin+4 more
semanticscholar +1 more source